Heaves hit for Stirling
Tuesday, 29 July, 2008
Stirling Products [ASX: STI] has been granted an Australian patent or the treatment of heaves in horses with R-salbutamol.
The company has already been granted a patent for the same concept from South Africa, and Stirling representatives say they expect more grants to follow shortly.
A patent application for the inhaler device developed to help administer the drug, the Equinehaler, has also been lodged.
Heaves, also known as recurrent airway obstruction, affects an estimated 25-30 per cent of all horses in Europe and the US.
Stirling is also looking at using R-salbutamol - a highly purified version of salbutamol, better known as Ventolin - as a growth agent and as a treatment of obesity in dogs.
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...
Global study finds 250 genes linked to OCD
Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
